Snowden Capital Advisors LLC Astrazeneca PLC Transaction History

Snowden Capital Advisors LLC

  • $3.12 Billion
  • Q4 2024

A detailed history of Snowden Capital Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 43,428 shares of AZN stock, worth $3.22 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
43,428
Previous 44,805 3.07%
Holding current value
$3.22 Million
Previous $3.49 Million 18.5%
% of portfolio
0.09%
Previous 0.11%

Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$63.2 - $79.58 $87,026 - $109,581
-1,377 Reduced 3.07%
43,428 $2.85 Million
Q3 2024

Nov 14, 2024
BUY
$76.67 - $87.62 $37,184 - $42,495
485 Added 1.09%
44,805 $3.49 Million
Q2 2024

Aug 14, 2024
BUY
$66.81 - $80.83 $548,109 - $663,129
8,204 Added 22.72%
44,320 $3.46 Million
Q1 2024

May 15, 2024
SELL
$61.03 - $69.57 $46,321 - $52,803
-759 Reduced 2.06%
36,116 $2.45 Million
Q4 2023

Feb 14, 2024
BUY
$61.89 - $69.28 $169,207 - $189,411
2,734 Added 8.01%
36,875 $2.48 Million
Q3 2023

Nov 14, 2023
SELL
$64.85 - $71.7 $106,937 - $118,233
-1,649 Reduced 4.61%
34,141 $2.31 Million
Q2 2023

Aug 14, 2023
SELL
$69.91 - $75.81 $154,501 - $167,540
-2,210 Reduced 5.82%
35,790 $2.56 Million
Q1 2023

May 15, 2023
BUY
$63.15 - $71.6 $205,805 - $233,344
3,259 Added 9.38%
38,000 $2.64 Million
Q4 2022

Feb 13, 2023
BUY
$54.21 - $70.44 $107,118 - $139,189
1,976 Added 6.03%
34,741 $2.36 Million
Q3 2022

Nov 09, 2022
BUY
$53.02 - $135.75 $997,412 - $2.55 Million
18,812 Added 134.82%
32,765 $1.8 Million
Q2 2022

Aug 12, 2022
BUY
$59.26 - $71.14 $36,681 - $44,035
619 Added 4.64%
13,953 $921,000
Q1 2022

May 16, 2022
BUY
$55.72 - $67.12 $447,375 - $538,906
8,029 Added 151.35%
13,334 $884,000
Q4 2021

Feb 14, 2022
BUY
$54.02 - $63.83 $286,576 - $338,618
5,305 New
5,305 $309,000
Q3 2021

Feb 05, 2024
SELL
$55.56 - $60.79 $1.33 Million - $1.46 Million
-23,948 Reduced 70.14%
10,193 $612 Million
Q2 2021

Jan 08, 2024
BUY
$48.42 - $60.18 $93,741 - $116,508
1,936 Added 23.64%
10,124 $606 Million
Q1 2021

Jan 08, 2024
BUY
$47.16 - $54.44 $50,649 - $58,468
1,074 Added 15.1%
8,188 $407 Million
Q4 2020

Jan 08, 2024
BUY
$48.52 - $58.02 $44,007 - $52,624
907 Added 14.61%
7,114 $356 Million
Q3 2020

Jan 08, 2024
SELL
$53.07 - $61.1 $118,664 - $136,619
-2,236 Reduced 26.48%
6,207 $340 Million
Q2 2020

Jan 08, 2024
BUY
$43.1 - $55.31 $5,516 - $7,079
128 Added 1.54%
8,443 $447 Million
Q1 2020

Jan 08, 2024
BUY
$37.79 - $51.33 $51,621 - $70,116
1,366 Added 19.66%
8,315 $371 Million
Q4 2019

Jan 30, 2024
SELL
$42.46 - $50.46 $16,007 - $19,023
-377 Reduced 5.15%
6,949 $346 Million
Q4 2019

Jan 08, 2024
SELL
$42.46 - $50.46 $16,007 - $19,023
-377 Reduced 5.15%
6,949 $346 Million
Q3 2019

Jan 30, 2024
SELL
$40.12 - $45.47 $5,095 - $5,774
-127 Reduced 1.7%
7,326 $327 Million
Q3 2019

Jan 08, 2024
SELL
$40.12 - $45.47 $9.74 Million - $11 Million
-242,674 Reduced 97.07%
7,326 $327 Million
Q2 2019

Jan 30, 2024
SELL
$37.28 - $41.68 $994,928 - $1.11 Million
-26,688 Reduced 78.17%
7,453 $308 Million
Q2 2019

Jan 08, 2024
BUY
$37.28 - $41.68 $9.05 Million - $10.1 Million
242,638 Added 3295.82%
250,000 $308 Million
Q1 2019

Jan 08, 2024
SELL
$35.49 - $43.02 $41,168 - $49,903
-1,160 Reduced 13.61%
7,362 $298 Million
Q4 2018

Jan 08, 2024
BUY
$36.86 - $41.49 $3,243 - $3,651
88 Added 1.04%
8,522 $324 Million
Q3 2018

Jan 08, 2024
BUY
$34.76 - $39.72 $78,835 - $90,084
2,268 Added 36.78%
8,434 $334 Million
Q2 2018

Jan 08, 2024
SELL
$34.55 - $37.05 $8,153 - $8,743
-236 Reduced 3.69%
6,166 $216 Million
Q1 2018

Jan 08, 2024
SELL
$32.97 - $36.63 $64,819 - $72,014
-1,966 Reduced 23.49%
6,402 $224 Million
Q4 2017

Jan 08, 2024
SELL
$32.09 - $34.78 $246,515 - $267,179
-7,682 Reduced 47.86%
8,368 $290 Million
Q3 2017

Jan 08, 2024
SELL
$28.96 - $34.0 $54,647 - $64,158
-1,887 Reduced 10.52%
16,050 $544 Million
Q2 2017

Jan 08, 2024
SELL
N/A
-199 Reduced 1.1%
17,937 $611 Million
Q1 2017

Jan 08, 2024
SELL
N/A
-1,203 Reduced 6.22%
18,136 $565 Million
Q4 2016

Jan 08, 2024
SELL
N/A
-933 Reduced 4.6%
19,339 $528 Million
Q3 2016

Jan 08, 2024
BUY
N/A
9,417 Added 86.75%
20,272 $666 Million
Q2 2016

Jan 08, 2024
SELL
N/A
-23,286
10,855 $328 Million

Others Institutions Holding AZN

# of Institutions
1,356
Shares Held
512M
Call Options Held
6.08M
Put Options Held
4.44M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $230B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email